19.05.2020 Novavax Daily Analysis

19.05.2020 Novavax Daily Analysis

56.96usd ,+13.33 ,+30.55% Today Novavax is trading on 56.96usd the stock gained tremendously with 30.55%. The reason why the shares of this vaccine company are doing well is that there was yet another upgrade from bank B.Rely FBR. It was reported that the company raised its price target on the stock from 43usd to 53usd a share as their twelve-month target plus the 388million investment that it received from the Coalition for Epidemic Preparedness Innovations. The company announced that this money that they have received in a fund is going to be used to advance and speed up the clinical development of its SARS-CoV-2 vaccine candidate for Covid 19 and investors are developing positive energy for the stock for they are hoping that the vaccine is going to boost the revenue of the Company and also it is working on its regulatory filing with an experimental flu vaccine called NanoFlu and once it is approved the company is going to excel.